Recce Pharmaceuticals (ASX:RCE) Total Stockholders Equity : A$-4.99 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Recce Pharmaceuticals Total Stockholders Equity?

Recce Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$-4.99 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Recce Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 was A$-0.18. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Recce Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2024 was -0.16.

Recce Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Recce Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals Total Stockholders Equity Chart

Recce Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Stockholders Equity

Get a 7-Day Free Trial

2.31

20.50

10.06

-2.59

-9.52

Recce Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial													1.24	-2.59	0.53	-9.52	-4.99

Recce Pharmaceuticals (ASX:RCE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Recce Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-4.987	-	0)	/	28.152
	=	-0.18

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Recce Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.246	+	0.533)	/	-4.987
	=	-0.16

Recce Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Recce Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Recce Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (ASX:RCE) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

R9Q:Germany

Address

180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000

Website

https://www.recce.com.au

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. The company operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat diseases caused by various bacteria namely Sepsis, Neisseria gonorrhoeaei, Escherichia coli, Mycobacterium abscessus, and others.

Recce Pharmaceuticals Headlines

No Headlines